Takeda Cambridge Company
![](/storage/logos_100px/Takeda Cambridge.jpeg)
Takeda Cambridge Limited (TCB) and its subsidiary TSP, have established world-class target identification and validation capabilities. Together they have developed a promising pipeline of novel drug discovery targets and compounds in key areas of unmet medical need such as CNS disorders, chronic pain and urology indications, endocrinology and metabolic-related diseases.
Technology:
Others
Industry:
PharmTech
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Zip:
51-100
Founded Date:
1998-01-01
Employees Number:
51-100
Funding Status:
Late Stage Venture
Acquisitions Number:
2
Investors Number:
22340000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Series D
Last Funding Type:
info@takedacam.com
Register and Claim Ownership